AD Nucleis
FR-MF-000002215 · France · GREZIEU LA VARENNE
AD Nucleis is registered in the European database on medical devices as a manufacturer, with 7 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
Most frequent device types declared: AD Nucléis direct SARS-CoV-2_1-step RTCPR, Extraction and purification kit of NA for blood, Sequence.
Devices declared under this manufacturer
- AD Nucléis direct SARS-CoV-2_1-step RTCPR 48R
- AD Nucléis direct SARS-CoV-2_1-step RTCPR 96R
- Extraction and purification kit of NA for blood 24R IVD
- Extraction purification kit of NA for blood 96R IVD
- Sequence Evolution IVD
- Sequence PREP IVD
- This device is used to extract DNA/RNA from EDTA blood samples
Catalogue references include HQS_DICoV2_IVD48R, HQS_DICoV2_IVD96R, KIT-EP_14_112_I_PF, KIT-EP_24_112_I_PF, Kit-EP_96_112_I_PF, SEQ_EVO_IVD.
European nomenclature codes declared: W0105900101, W0105041106, W02050116, W02060101.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 7 |
| Country of registration | France |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 7 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. AD Nucleis was not found in either the U.S. or the Canadian register.